More Information Coming Soon
Future Home of Belgravia Capital International

About Belgravia Capital

Belgravia Capital International Inc. is focused on its three core business divisions: Incubation, Investments and also Royalty and Management Services. Belgravia will also develop new companies with a focus on the cannabis industry.  The Incubation division will provide services to support the development of early-stage companies in the Cannabis space and other technology areas.   Belgravia Holdings, the Investments division, invests in various private and public companies with a focus on licit cannabis, technology, and, on an opportunistic basis, resources.   Belgravia Royalty and Management Services has developed a targeted royalty and fee income model. In the Cannabis space, the Company’s geographic focus is primarily in Canada.  Further, the developing cash and investment asset base can also support international expansion on a selective basis.  Canada has powerful national government legislation leadership in Cannabis, Cannabis friendly and supportive physicians, and the world’s strongest Cannabis capital markets. 

Latest News

April 18, 2018
Belgravia Appoints Dr. Sam Hanna Chief Medical Officer Of Cannabis Dermatology Division

March 12, 2018
BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

February 28, 2018
BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000.

January 25, 2018
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

January 12, 2018
BELGRAVIA CAPITAL INTERNATIONAL announces closing of private placement

January 10, 2018
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments

January 4, 2018

January 3, 2018
BELGRAVIA CAPITAL INTERNATIONAL moves to build fully-owned subsidiary in Blockchain and Cannabis Industry

December 5, 2017

November 22, 2017
IC Potash announces trading date on Canadian Securities Exchange under new name ‘Belgravia Capital International’

November 20, 2017
IC Potash provides update on listing on Canadian Stock Exchange

November 7, 2017
IC Potash announces pending move of trading venue to Canadian Securities Exchange

November 6, 2017
IC Potash announces expanded ICP Organics development strategy to include value-added cannabis industry products and services, including permissioned and private blockchain technologies

Annual Meeting 2018

View Annual and Special Meeting Materials


2017 Annual Audited Financial Statements

2017 Annual Management’s Discussion and Analysis


Telephone & Email

Jason Batista: + 1 416 579 6850


Belgravia Capital International
Administration Department
#3-3185 Via Centrale
Kelowna, BC V1V 2A7